Adverse Events FDA received an adverse event report on January 14, 2019, regarding seven patients in an outpatient clinic who received intravenous injections containing L-glutathione 200mg/mL compounded by a pharmacy using L-glutathione repackaged by Letco (lot number: 1810150050, expiration date: 6/17/2020)
doi: 10.1002/psc.2420 [DOI] [PubMed] [Google Scholar] 208.Dathe M, Nikolenko H, Meyer J, Beyermann M, Bienert M
For purity and quality, ACG Glutathione Extra Strength contains no preservatives no alcohol no artificial coloring or flavoring
Elevate Your Performance & Recovery: Quicksilver Scientifics Liposomal Peptides Feb 21 3 min read In the quest for peak performance, faster recovery, and enhanced overall wellness, more people are turning to advanced nutritional and therapeutic tools that work at a cellular level